WG
KURA icon

Winton Group’s Kura Oncology KURA Stock Holding History

Winton Group’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$143K Buy
13,000
+2,700
+26% +$25.5K ﹤0.01% 1049
2026
Q1 		$83.7K Sell
10,300
-23,657
-70% -$203K ﹤0.01% 1050
2025
Q4 		$353K Buy
+33,957
New +$356K 0.01% 712
2022
Q2 		– Sell
-20,196
Closed -$325K – 1015
2022
Q1 		$325K Sell
20,196
-7,341
-27% -$106K 0.02% 800
2021
Q4 		$386K Buy
+27,537
New +$446K 0.02% 753
2021
Q3 		– Sell
-12,666
Closed -$264K – 1417
2021
Q2 		$264K Sell
12,666
-4,639
-27% -$115K 0.01% 1253
2021
Q1 		$489K Sell
17,305
-8,522
-33% -$270K 0.03% 905
2020
Q4 		$844K Sell
25,827
-37,074
-59% -$1.3M 0.06% 499
2020
Q3 		$1.93M Buy
62,901
+2,002
+3% +$44.2K 0.06% 540
2020
Q2 		$993K Buy
60,899
+13,744
+29% +$198K 0.03% 969
2020
Q1 		$469K Sell
47,155
-7,569
-14% -$86.6K 0.01% 1051
2019
Q4 		$752K Buy
+54,724
New +$811K 0.01% 1132
2019
Q2 		– Sell
-13,579
Closed -$225K – 1218
2019
Q1 		$225K Sell
13,579
-272
-2% -$4.19K ﹤0.01% 915
2018
Q4 		$194K Sell
13,851
-4,741
-26% -$62.8K ﹤0.01% 814
2018
Q3 		$325K Buy
+18,592
New +$356K 0.01% 784

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Winton Group's KURA Position: Q2 2026 in Review

Winton Group increased its Kura Oncology (KURA) stake by 26% in Q2 2026, buying an estimated $25.5K and bringing the position to 13,000 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #1049.

Winton Group first reported a position in KURA in Q3 2018 and has held it in 15 quarters since. The position peaked at $1.93M in Q3 2020. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Winton Group held 13,000 shares of Kura Oncology worth $143K as of Q2 2026.
  • Winton Group bought 2,700 Kura Oncology shares in Q2 2026, an estimated $25.5K.
  • Kura Oncology made up ﹤0.01% of Winton Group's portfolio in Q2 2026, its #1049 holding.
  • Winton Group first reported a position in Kura Oncology in Q3 2018 and has held it in 15 quarters since.
  • Winton Group's Kura Oncology position peaked at $1.93M in Q3 2020.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.